Nemolizumab Uses, Dosage, Side Effects and more
Nemolizumab is under investigation in clinical trial NCT03921411 (A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Subjects With Atopic Dermatitis (AD)).
| Attribute | Details |
|---|---|
| Trade Name | Nemolizumab |
| Generic | Nemolizumab |
| Nemolizumab Other Names | Nemolizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
